Chad vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
Chad
100.0%
in 2024
Sur
82.0%
in 2024
Chad rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Chad
- Sur
How they compare
Chad currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Chad's figure about 1.2 times Sur's.
The two have swapped places 2 times across 14 shared years of data; in 2010 it was Chad ahead.
Chad ranks 1st and Sur ranks 2nd of 144 countries.
Across the 2 decades both report, Chad averaged higher in 1 and Sur in 1.
Head to head by decade
| Decade | Chad | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 61.1% | 64.3% | 3.2% | Sur |
| 2020s | 99.4% | 75.8% | 23.6% | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Chad or Sur?
- Chad, at 100.0% against 82.0% in Sur as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Chad and Sur?
- 18.0%, with Chad ahead.
- How many years of comparable data are there for Chad and Sur?
- 14 years are reported by both, from 2010 to 2024.
- How do Chad and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Chad ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.